Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
topsalysin (6 trials)
prx-321 (1 trial)
psa-pah1 (1 trial)
Glioblastoma (Phase 2)
Hyperplasia (Phase 3)
Lower Urinary Tract Symptoms (Phase 3)
Prostatic Hyperplasia (Phase 3)
Prostatic Neoplasms (Phase 2)
Trials (8 total)
Trial APIs (3 total)